HAPLOIDENTICAL TRANSPLANT HAS SUPERIOR GRAFT-VERSUS-LEUKEMIA EFFECT THAN HLA-MATCHED SIBLING TRANSPLANT FOR PH- HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Menglin Fan, 325110

VENETOCLAX PLUS DECITABINE IN THE TREATMENT OF MRD-PERSISTENT AND RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Galina Isinova, 325111

PROGNOSTIC FACTORS IN INFANTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND 11Q23/KMT2A REARRANGEMENTS ENROLLED IN MLL-BABY TRIAL

EHA Library, Grigory Tsaur, 325112

IMPROVED LONG-TERM SURVIVAL AFTER ALLOGENEIC TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: A DANISH POPULATION-BASED STUDY

EHA Library, Lars Klingen Gjærde, 325113

TWO CONSECUTIVE MULTICENTER RUSSIAN ACUTE LYMPHOBLASTIC LEUKEMIA (RALL) STUDIES IN PH-NEGATIVE ADULT ALL: SUCCESSES AND PITFALLS

EHA Library, Elena Parovichnikova, 325114

IMMUNOPHENOTYPE OF RESIDUAL BLASTS, NOT ONLY MRD-POSITIVITY, DOES MATTER IN LONG-TERM PROGNOSIS OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yulia Davydova, 325115

PEG ASPARAGINASE INDUCED SEVERE HYPERTRIGLYCERIDEMIA IN ADULTS ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC-INSPIRED REGIMEN: IS IT SAFE TO RECHALLENGE THESE PATIENTS?

EHA Library, Ibrahim Al Nabhani, 325116

ACUTE LYMPHOBLASTIC LEUKEMIA AND SARS-COV-2, RESPONSE TO TREATMENT AND SPONTANEOUS REMISSIONS. EXPERIENCE OF TWO COVID-19 HOSPITALS IN MEXICO CITY.

EHA Library, Christian Ramos, 325117

OUTCOME OF RELAPSED OR REFRACTORY ACUTE B-LYMPHOBLASTIC LEUKEMIA PATIENTS WITH EXTRAMEDULLARY DISEASE RECEIVING INOTUZUMAB OZOGAMICIN

EHA Library, Sabine Kayser, 325118

ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE: A SINGLE CENTRE RETROSPECTIVE REVIEW OF DISEASE CHARACTERISTICS, TREATMENT STRATEGIES, OUTCOMES AND NOVEL THERAPEUTIC TARGETS

EHA Library, Kevin Brown, 325119

HETEROGENEITY OF TREATMENT RESPONSE DEFINITIONS IN REFRACTORY/RELAPSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (R/R ALL): FINDINGS FROM A SYSTEMATIC LITERATURE REVIEW (SLR) OF CLINICAL TRIALS

EHA Library, Sam Keeping, 325120

A PHASE II STUDY OF BLINATUMOMAB FOR THE TREATMENT OF MEASURABLE RESIDUAL DISEASE-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Nicholas Short, 325121

EPIDEMIOLOGY, TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS IN TAIWAN: A POPULATION-BASED COHORT STUDY

EHA Library, Meng-Yao Lu, 325122

CORRELATION OF BLINATUMOMAB THERAPY IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA OUTCOME WITH MINIMAL RESIDUAL DISEASE, CYTOGENETICS AND ABSOLUTE LYMPHOCYTE COUNT:RETROSPECTIVE MULTICENTER STUDY.

EHA Library, Mohammed Essa, 325123

THE PATIENT EXPERIENCE OF ACUTE LYMPHOBLASTIC LEUKEMIA AND ITS TREATMENT: A SOCIAL MEDIA REVIEW

EHA Library, Ross Morrison, 325124

INOTUZUMAB OZOGAMICIN IN RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA: A REAL-WORLD RETROSPECTIVE STUDY IN THE UK

EHA Library, David Marks, 325125

3D GENOMICS OF ACUTE MEYLOID LEUKEMIA REVEALS THE IMBALANCE BETWEEN DNA METHYLATION CANYON INTERACTIONS AND LEUKEMIC SPECIFIC ENHANCER NETWORK INTERACTIONS

EHA Library, Xiaotian Zhang, 325126

FUNCTIONAL COOPERATION OF CEBPA AND TET2 MUTATIONS IN ACUTE MYELOID LEUKEMIA

EHA Library, Elizabeth Heyes, 325127

HNRNP K OVEREXPRESSION CONTRIBUTES TO POOR PROGNOSIS AND CHEMORESISTANCE IN AML BY DEVELOPING SUPER-NUCLEOLUS

EHA Library, Pedro Aguilar-Garrido, 325128

IDH MUTATIONS DRIVE LEUKEMOGENESIS BY ONCOGENIC ACTIVATION DUE TO INSULATOR DYSFUNCTION

EHA Library, Sophie Steinhäuser, 325129

NEXT-GENERATION SEQUENCING (NGS)-BASED MEASURABLE RESIDUAL DISEASE (MRD) MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION (FLT3-ITD+ AML) TREATED WITH ADDITIONAL MIDOSTAURIN

EHA Library, Julia K. Herzig, 325130

AGEING MIMICS LEUKEMIC ADAPTATION OF BONE MARROW STROMAL CELLS AND PROMOTES ACUTE MYELOID LEUKEMIA INITIATION

EHA Library, Xiying Ren, 325131

SELECTIVE REQUIREMENT OF MYB FOR ONCOGENIC HYPERACTIVATION OF A TRANSLOCATED ENHANCER IN ACUTE MYELOID LEUKEMIA

EHA Library, Leonie Smeenk, 325132

MENIN INHIBITION DECREASES BCL-2 AND SYNERGIZES WITH VENETOCLAX IN NPM1/FLT3-MUTATED AML

EHA Library, Bing Carter, 325133

IDENTIFICATION OF FUNCTIONAL GENETIC DEPENDENCIES AND DIRECT TRANSCRIPTIONAL TARGET GENES OF NUP98-JARID1A IN ACUTE MYELOID LEUKEMIA

EHA Library, Selina TROESTER, 325134

FUNCTIONAL ANALYSIS OF ABERRANT GENE REGULATORY PROGRAMS AND SELECTIVE DEPENDENCIES IN EVI1/MECOM-DRIVEN ACUTE MYELOID LEUKEMIA

EHA Library, Johannes Schmoellerl, 325135

NUP98/NSD1-POSITIVE AML IS ADDICTED TO A FUNCTIONAL MENIN-MLL INTERACTION

EHA Library, Milad Rasouli, 325136

MECHANISTIC STUDIES OF TENOFOVIR-DERIVED TYROSINE KINASE INHIBITORS TARGETING FLT3 IN ACUTE MYELOID LEUKEMIA

EHA Library, Inga KF Motzfeldt, 325137

CIRCULATING EXTRACELLULAR VESICLES FROM ACUTE MYELOID LEUKEMIA PATIENTS REVEAL SPHINGOLIPID DEPLETION AND REDOX METABOLIC FUNCTION

EHA Library, Dorian Forte, 325138

FILT3R: AN NGS-BASED ALGORITHM FOR ROBUST DETECTION AND QUANTIFICATION OF FLT3-ITD IN CLINICAL PRACTICE

EHA Library, Augustin Boudry, 325139

FREQUENCY AND STIMULATION OF NPM1-SPECIFIC IMMUNE RESPONSES BY ANTI-PD1 ANTI-BODIES IN NPM1-MUTATED AML

EHA Library, Jochen Greiner, 325140

TARGETING THE IRE1Α-XBP1 PATHWAY INDUCES APOPTOSIS IN FLT3-ITD+ AML AND ENHANCES THE EFFECT OF TKI INDUCED FLT3-ITD INHIBITION

EHA Library, Timo Jaquet, 325141

SWATH-MS PROTEOMIC ANALYSIS IDENTIFIES C/EBPΒ SUPPRESSION BY RUNX1-ETO AS A POTENTIAL MEDIATOR OF BLOCK IN DIFFERENTIATION

EHA Library, Aleksandra Azevedo, 325142

GLUTATHIONE HOMEOSTASIS AND ABCC1 (MRP1) MODULATE THE RESPONSE OF ACUTE MYELOID LEUKEMIA (AML) CELLS TO BCL2 INHIBITION

EHA Library, Jessica Ebner, 325143

IRAK4 INHIBITOR CA-4948 POTENTIATES ANTITUMOR EFFECTS OF AZACITIDINE AND VENETOCLAX IN HUMAN ACUTE MYELOID LEUKEMIA

EHA Library, Andrey Ugolkov, 325144

RECURRENT DELETIONS IN CLONAL HEMATOPOIESIS ARE DRIVEN BY MICROHOMOLOGY-MEDIATED END JOINING

EHA Library, Tzah Feldman, 325145

TARGETING THE RUNX1-RUNX1T1 FUSION GENE USING CRISPR-CAS9 TECHNOLOGY EFFECTIVELY INHIBITS PROLIFERATION AND DECREASES TUMOR VOLUME IN VITRO AND IN VIVO

EHA Library, Signe Neldeborg, 325146

CANONICAL WNT SIGNALING-RESPONSIVE ACUTE MYELOID LEUKEMIA CELLS ARE DEPENDENT ON BETA-CATENIN BUT NOT GAMMA-CATENIN FOR CLONAL GROWTH

EHA Library, Adam Leckenby, 325147

BASELINE SOMATIC MUTATIONS PREDICT DISEASE FREE SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE MONOCENTRIC REPORT

EHA Library, Patrizia Chiusolo, 325148

NK-CELLS EXHAUSTION WHICH DUE TO NKG2A OVER-EXPRESSION IS ASSOCIATE WITH RELAPSED IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Xue-Fei Liu, 325149

LONGITUDINAL PATIENT-DERIVED XENOGRAFT MODELS REVEAL CONVERGENT MOLECULAR EVOLUTION IN ACUTE MYELOID LEUKAEMIA

EHA Library, Tara Helen Dowling, 325150

DIFFERENTIATION OF ACUTE MYELOID LEUKEMIA SUBTYPES BY SERUM-BASED SPECTROSCOPY COUPLING WITH NON-TARGETED METABOLIC FINGERPRINTS

EHA Library, Yang Chen, 325151

MEGAKARYOCYTIC TRANSCRIPTION FACTOR ARID3A SUPPRESSES GATA1S-INDUCED MALIGNANT TRANSFORMATION

EHA Library, Oriol Alejo-Valle, 325152

SIGNALLING INTERACTIONS OF MEGAKARYOCYTE-ERYTHROID PROGENITOR CELLS AT TIME OF DIAGNOSIS PREDICT SURVIVAL IN ACUTE MYELOID LEUKAEMIA

EHA Library, Dimitrios Kleftogiannis, 325153

THE NOVEL ORAL BET-CBP/P300 DUAL INHIBITOR NEO2734 IS HIGHLY EFFECTIVE IN ERADICATING ACUTE MYELOID LEUKEMIA BLASTS AND STEM/PROGENITOR CELLS

EHA Library, Noortje van Gils, 325154

POLYFUNCTIONALITY DETERMINED BY SINGLE-CELL PROTEOMICS OF BONE MARROW-DERIVED CD4 T-CELLS FROM PATIENTS WITH ACUTE MYELOID LEUKEMIA PREDICTS PATIENTS RESPONDING TO ANTI-PD-1-BASED THERAPY

EHA Library, Hussein Abbas, 325155

RAPID GENOMIC PROFILING IN ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CYTOGENETIC ABERRATIONS

EHA Library, Anna Dolnik, 325156

ENHANCED EFFICACY OF THE DCP-001 RELAPSE VACCINE WHEN COMBINED WITH VENETOCLAX AND 5-AZACITIDINE IN A HUMANISED IMMUNOCOMPETENT MOUSE MODEL OF AML

EHA Library, Satwinder Kaur Singh, 325157

TARGETING DOWN SYNDROME-ASSOCIATED LEUKEMIA AT ITS CORE: LSD1 INHIBITION IN COMBINATION WITH DISRUPTION OF JAK-STAT SIGNALING

EHA Library, Juliane Grimm, 325158

MESENCHYMAL STROMAL CELLS PROTECT ACUTE MYELOID LEUKEMIA CELLS FROM VENETOCLAX-INDUCED APOPTOSIS THROUGH CONTACT-DEPENDENT MECHANISMS

EHA Library, Giulia Corradi, 325159

TREATMENT IS SHAPING CLONAL EVOLUTION AND RESISTANCE PATTERNS IN MURINE KMT2A-REARRANGED LEUKEMIA WITH SUBCLONAL FLT3N676K

EHA Library, Ton Falqués-Costa, 325160

COMPUTER AIDED DESIGN (CAD) FLOW IN ASSESSMENT OF AML MRD FLOW -ALFA FRENCH FLOW AML MRD INTERGROUP

EHA Library, Florent Dumezy, 325161

THE IMPACT OF MUTATIONAL LOAD (VAF) DETECTED IN THE TP53, EZH2, U2AF1, WT1, FLT3 AND SF3B1 GENES WAS IDENTIFIED AS AN INDEPENDENT PROGNOSTIC MARKER FOR OS OR RFS IN A COHORT OF 497 CASES WITH AML

EHA Library, Noemí Álvarez Sánchez-Redondo, 325162

LONG NON-CODING RNA FAM30A AS A NOVEL REGULATOR OF LEUKEMIC STEM CELL FATE IN ACUTE MYELOID LEUKEMIA

EHA Library, Jaime Calvo Sánchez, 325163

COMBINATORIAL INHIBITION OF TIGIT AND CD39 INCREASE T-CELL MEDIATED KILLING IN AML

EHA Library, Franziska Brauneck, 325164

NEW CUSTOM ALGORITHM FOR COPY NUMBER DETECTION IN MYELOID MALIGNANCIES USING A TARGETED NGS PANEL

EHA Library, Beñat Ariceta, 325165

STUDY OF THE ROLE OF SR PROTEINS IN CYTARABINE TREATMENT RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, María Luz Morales, 325166

ANALYSIS OF GERMLINE PREDISPOSITION IN PATIENTS WITH MYELOID NEOPLASMS: ASSOCIATION BETWEEN MOLECULAR ALTERATIONS AND CLINICAL HISTORY

EHA Library, Marta Santiago Balsera, 325167

THE MOLECULAR BASIS AND CLINICAL OUTCOMES OF CALM-MLLT10 FUSION POSITIVE ACUTE LEUKEMIA

EHA Library, Tong Wang, 325168

PRL-PRLR AXIS IMPLICATION IN CHEMORESISTANCE AND PROLIFERATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Laia Cuesta-Casanovas, 325169

MAIT CELLS NUMBERS AND FREQUENCIES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AT DIAGNOSIS: ASSOCIATION WITH CYTOGENETIC PROFILE AND GENE MUTATIONS.

EHA Library, Thibault Comont, 325170

PRECLINICAL DEVELOPMENT OF NOVEL COMBINED CSF1R/FLT3 INHIBITORS IN ACUTE MYELOID LEUKEMIA

EHA Library, Kristine Sletta, 325171

CHECKPOINT KINASE 1 IS OVEREXPRESSED, BY POST-TRANSCRIPTIONAL REGULATION, IN IMMATURE AND MONOBLASTIC / MONOCYTIC ACUTE MYELOID LEUKEMIA

EHA Library, Leonor M. Sarmento, 325172

DEEP HYPOXIA REDUCES SENSITIVITY OF ACUTE MYELOID LEUKEMIA CELL LINES TO THE PAN-AURORA INHIBITOR TOZASERTIB

EHA Library, Samantha Bruno, 325173

METABOLIC PECULIARITY OF PML/RARA EXPRESSING CELLS AND ARSENIC TRIOXIDE RESISTANCE

EHA Library, Nelida I. Noguera, 325174

ZINC IN THE MODULATION OF THE DNA DAMAGE RESPONSE – PREVENTIVE, GENOTOXIC AND CYTOTOXIC ROLES IN ACUTE MYELOID LEUKEMIA

EHA Library, Ana Bela Sarmento-Ribeiro, 325175

LINKING CDK6 TO THE EPIGENOME

EHA Library, Karoline Kollmann, 325176

GENOMIC LANDSCAPE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA OLDER THAN 70 YEARS

EHA Library, Frank Rücker, 325177

MELFLUFEN DEMONSTRATES HIGH EFFICACY IN CYTARABINE AND VENETOCLAX RESISTANT AML MODELS

EHA Library, Ana Slipicevic, 325178

ASSOCIATION OF ATG10 FUNCTIONAL GENETIC VARIANTS IN ACUTE MYELOID LEUKEMIA

EHA Library, Anabela Areias, 325179

IL-3 RESCUES MUTANT FLT3 AND KIT-POSITIVE AML CELLS FROM TARGETED THERAPY

EHA Library, Elmira Vagapova, 325180

TAGRAXOFUSP IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM: LONG-TERM RESULTS FROM A PIVOTAL TRIAL

EHA Library, Naveen Pemmaraju, 325181

PROGNOSTIC FACTORS OF OVERALL AND RELAPSE-FREE SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION: MULTIVARIATE ANALYSES FROM THE QUAZAR AML-001 TRIAL OF ORAL AZACITIDINE (ORAL-AZA )

EHA Library, Gail Roboz, 325182

TREATMENT FREE REMISSION (TFR) AFTER CEASING VENETOCLAX-BASED THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Chong Chyn Chua, 325183

QUIZARTINIB WITH DECITABINE AND VENETOCLAX (TRIPLET) IS HIGHLY ACTIVE IN PATIENTS WITH FLT3-ITD MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Musa Yilmaz, 325184

SECOND ALLOGENEIC STEM CELL TRANSPLANTATION FOR SECONDARY AML RELAPSING AFTER FIRST TRANSPLANTATION-A COMPARISON BETWEEN MYELOABLATIVE AND REDUCED INTENSITY CONDITIONING: FROM THE ALWP OF THE EBMT

EHA Library, Arnon Nagler, 325185

VALIDATION AND CLINICAL APPLICATION OF AN UNSUPERVISED ANALYSIS APPROACH TO MEASURABLE RESIDUAL DISEASE TESTING IN ACUTE MYELOID LEUKEMIA

EHA Library, Nicholas McCarthy, 325186

COMPARATIVE BIOAVAILABILITY OF A NOVEL ORAL FORMULATION OF ARSENIC TRIOXIDE IN PATIENTS UNDERGOING CONSOLIDATION THERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA: FINAL ANALYSIS OF THE ALLG APML5 TRIAL

EHA Library, Harry J Iland, 325187

AGE-SPECIFIC CONDITIONAL RELATIVE SURVIVAL AMONG LONG-TERM ACUTE MYELOID LEUKEMIA (AML) SURVIVORS IN THE NETHERLANDS

EHA Library, Avinash Dinmohamed, 325188

CLINICAL IMPACT OF SENSITIVE DNMT3A, TET2, OR ASXL1 MUTATION DETECTION IN ACUTE MYELOID LEUKEMIA PATIENTS PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Madlen Jentzsch, 325189

PREVALENCE AND PROGNOSTIC IMPACT OF IDH MUTATIONS IN THE REAL-WORLD SETTING: RESULTS FROM THE PROSPECTIVE IDH SCREENING COHORT OF THE SAL AML REGISTRY

EHA Library, Christoph Röllig, 325190

A PHASE 1 STUDY OF GILTERITINIB IN COMBINATION WITH INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED AML: FINAL RESULTS UPDATE

EHA Library, Keith Pratz, 325191

FOLLOW-UP OF PATIENTS WITH FLT3-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA IN THE PHASE 3 ADMIRAL TRIAL

EHA Library, Mark Levis, 325192

CYTOPENIA MANAGEMENT IN THE PHASE 3 VIALE-C STUDY OF VENETOCLAX PLUS LOW-DOSE CYTARABINE FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Andrew Wei, 325193

PROGNOSTIC IMPACT OF CONVENTIONAL CYTOGENETICS IN ACUTE MYELOID LEUKEMIA (AML) TREATED WITH DECITABINE AND VENETOCLAX (DEC10-VEN)

EHA Library, Sangeetha Venugopal, 325194

OUTCOMES IN GILTERITINIB-TREATED FLT3-MUTATED R/R AML PATIENTS WHO UNDERWENT TRANSPLANTATION

EHA Library, Alexander Perl, 325195

PRELIMINARY RESULTS OF V-FAST, A PHASE 1B MASTER TRIAL TO INVESTIGATE CPX-351 COMBINED WITH TARGETED AGENTS IN NEWLY DIAGNOSED AML

EHA Library, Vinod A. Pullarkat, 325196

PHASE 1 FIRST-IN-HUMAN STUDY OF IRREVERSIBLE FLT3 INHIBITOR FF-10101-01 IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Mark Levis, 325197

RELATIONSHIP BETWEEN VENETOCLAX EXPOSURE AND POST-REMISSION CYTOPENIAS IN SUBJECTS WITH TREATMENT-NAÏVE ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX PLUS AZACITIDINE IN THE VIALE-A STUDY

EHA Library, Deanna Brackman, 325198

HEMATOLOGIC ADVERSE EVENTS AND MANAGEMENT STRATEGIES FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN FIRST REMISSION RECEIVING ORAL AZACITIDINE (ORAL-AZA) IN THE PHASE 3 QUAZAR AML-001 TRIAL

EHA Library, Farhad Ravandi-Kashani, 325199

COMPARATIVE EFFICACY OF ORAL VERSUS INJECTABLE AZACITIDINE IN PATIENTS WITH AML IN FIRST REMISSION AFTER INTENSIVE CHEMOTHERAPY: AN INDIRECT TREATMENT COMPARISON (SUB-ANALYSIS UPDATE)

EHA Library, Clara Chen, 325200

MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VERSUS INTENSIVE CHEMOTHERAPY IN FLT3 MUTATED ACUTE MYELOID LEUKEMIA. A RWE STUDY

EHA Library, Adolfo De La Fuente, 325201

CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA TREATED WITH GILTERITINIB WHO RECEIVED PRIOR MIDOSTAURIN OR SORAFENIB

EHA Library, Zheng Ge, 325208

CLONAL HEMATOPOIESIS IN PERIPHERAL STEM CELLS AT LEUKAPHERESIS AS PREDICTIVE FACTOR FOR THERAPY-RELATED MYELOID NEOPLASMS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Doriana Gramegna, 325209

ALICE MAINTAINS HIGH CLINICAL RESPONSE RATES SUPPORTING THE EFFICACY OF IADADEMSTAT COMBINATION WITH AZACITIDINE IN AML MANAGEMENT

EHA Library, Olga Salamero, 325210

ALLOGENIC STEM CELL TRANSPLANTATION ABROGATES NEGATIVE IMPACT ON OUTCOME OF AML PATIENTS WITH KMT2A PARTIAL TANDEM DUPLICATION

EHA Library, Gabriel Antherieu, 325211

A PHASE 1A/B DOSE ESCALATION STUDY OF THE MYC REPRESSOR APTO-253 IN PATIENTS WITH RELAPSED OR REFRACTORY AML OR HIGH-RISK MDS

EHA Library, Rafael Bejar, 325212

SYNERGISTIC EFFECT OF AZACITIDINE AND HOMOHARRINGTONINE IN ACUTE MYELOID LEUKEMIA WITH GATA2 MUTATION

EHA Library, Zheng Ge, 325213

MONITORING OF POST-TRANSPLANT MLL-PTD AS MINIMAL RESIDUAL DISEASE CAN PREDICT RELAPSE AFTER ALLOGENEIC HSCT IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

EHA Library, Mengge Gao, 325214

RESULTS FROM DIAMOND-01 (CLI24-001) TRIAL: FIRST IN HUMAN STUDY OF SEL24/MEN1703, A DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Scott Solomon, 325215